Buy & Sell Danaos Corporation (DAC) – Danaos Corporation Price Today
Aura AI Summary
Key Stats
- $2.29BMarket Cap
- TechnologySector
- -7%3M Drawdown
- $2.30BEnterprise Value
- 2.86%Dividend Yield
- 20 daysTypical Hold Time
Danaos Corporation (DAC) is currently valued at a market capitalization of $2.29B, with an enterprise value of $2.30B. Over the past 52 weeks, Danaos Corporation has traded between a low of $84.05 and a high of $134.63, highlighting its annual price range. Over the past three months, Danaos Corporation has recorded a drawdown of -7%, reflecting recent price volatility. Danaos Corporation offers a dividend yield of 2.86%, with the most recent dividend of $0.90 paid on 26 May 26. On average, investors hold Danaos Corporation for approximately 20 days, indicating typical investor behavior on the platform.
About Danaos Corporation
Danaos is a leading international owner of containerships, providing seaborne transportation services globally. It charters its fleet of vessels to major shipping lines across Asia, Europe, and the Americas.
Most Recent News
Medical alert systems market to grow to $23.5B by 2035 driven by aging population and tech advances
The global medical alert systems market is projected to grow from $10.5 billion in 2025 to $23.5 billion by 2035, at a CAGR of 8.45%. Growth is fueled by an increasing elderly population preferring to age in place and advances in mobile and standalon...

Helium market to reach $8.59B by 2035 driven by MRI and semiconductor demand growth
The global helium market, valued at $5.03 billion in 2025, is projected to grow to $8.59 billion by 2035 with a CAGR of 5.47%. Growth is fueled by rising demand in healthcare for MRI superconducting magnet cooling and expanding semiconductor manufact...

Dimethylformamide market to reach $4.54B by 2035 driven by pharma and industrial demand growth.
The global dimethylformamide (DMF) market, valued at $2.79 billion in 2025, is projected to grow at a CAGR of 4.98% to reach $4.54 billion by 2035. Growth is fueled by expanding pharmaceutical API manufacturing, especially in India, China, and Europe...
